Bioxyne Ltd (BXN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bioxyne Ltd (BXN) has a cash flow conversion efficiency ratio of -0.064x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.29 Million ≈ $-915.87K USD) by net assets (AU$20.17 Million ≈ $14.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Bioxyne Ltd stock valuation for the company's overall valuation and market capitalisation.
Bioxyne Ltd - Cash Flow Conversion Efficiency Trend (2000–2025)
This chart illustrates how Bioxyne Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Bioxyne Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bioxyne Ltd ranked by their cash flow conversion efficiency. Explore Bioxyne Ltd cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Samwha Electri
KO:009470
|
0.025x |
|
Black Mammoth Metals Corp
V:BMM
|
-0.010x |
|
KUB Malaysia Bhd
KLSE:6874
|
0.012x |
|
Sonadezi Chau Duc Shareholding Co
VN:SZC
|
N/A |
|
Maywood Acquisition Corp. Class A Ordinary Shares
NASDAQ:MAYA
|
-0.002x |
|
Glintt
LS:GLINT
|
0.004x |
|
Kjell Group AB
ST:KJELL
|
0.245x |
|
Hansol Paper Co Ltd
KO:213500
|
0.048x |
Annual Cash Flow Conversion Efficiency for Bioxyne Ltd (2000–2025)
The table below shows the annual cash flow conversion efficiency of Bioxyne Ltd from 2000 to 2025. View today's stock price for Bioxyne Ltd for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$11.38 Million ≈ $8.05 Million |
AU$6.28 Million ≈ $4.44 Million |
0.552x | +151.14% |
| 2024-06-30 | AU$3.30 Million ≈ $2.33 Million |
AU$-3.56 Million ≈ $-2.52 Million |
-1.079x | -1331.48% |
| 2023-06-30 | AU$15.01 Million ≈ $10.62 Million |
AU$-1.13 Million ≈ $-800.27K |
-0.075x | -105.43% |
| 2022-06-30 | AU$-364.84K ≈ $-258.15K |
AU$-506.81K ≈ $-358.60K |
1.389x | +4955.72% |
| 2021-06-30 | AU$1.93 Million ≈ $1.37 Million |
AU$53.13K ≈ $37.60K |
0.027x | +48.59% |
| 2020-06-30 | AU$2.61 Million ≈ $1.85 Million |
AU$48.25K ≈ $34.14K |
0.018x | +104.18% |
| 2019-06-30 | AU$3.14 Million ≈ $2.22 Million |
AU$-1.39 Million ≈ $-983.77K |
-0.442x | -3.07% |
| 2018-06-30 | AU$4.32 Million ≈ $3.06 Million |
AU$-1.86 Million ≈ $-1.31 Million |
-0.429x | -318.22% |
| 2017-06-30 | AU$4.13 Million ≈ $2.92 Million |
AU$-424.05K ≈ $-300.04K |
-0.103x | -145.65% |
| 2016-06-30 | AU$1.55 Million ≈ $1.10 Million |
AU$348.85K ≈ $246.84K |
0.225x | +273.10% |
| 2015-06-30 | AU$1.28 Million ≈ $908.28K |
AU$-166.77K ≈ $-118.00K |
-0.130x | -122.95% |
| 2014-06-30 | AU$1.07 Million ≈ $758.45K |
AU$606.76K ≈ $429.32K |
0.566x | -87.72% |
| 2013-06-30 | AU$-210.73K ≈ $-149.10K |
AU$-971.70K ≈ $-687.54K |
4.611x | +678.23% |
| 2012-06-30 | AU$5.89 Million ≈ $4.17 Million |
AU$-4.70 Million ≈ $-3.32 Million |
-0.797x | -29.84% |
| 2011-06-30 | AU$124.34K ≈ $87.98K |
AU$-76.37K ≈ $-54.04K |
-0.614x | -149.79% |
| 2010-06-30 | AU$123.29K ≈ $87.23K |
AU$152.07K ≈ $107.60K |
1.233x | +110.83% |
| 2009-06-30 | AU$43.15K ≈ $30.53K |
AU$-491.48K ≈ $-347.75K |
-11.391x | -751.42% |
| 2008-06-30 | AU$-623.12K ≈ $-440.90K |
AU$-1.09 Million ≈ $-770.99K |
1.749x | +128.21% |
| 2007-06-30 | AU$218.65K ≈ $154.71K |
AU$-1.36 Million ≈ $-958.87K |
-6.198x | -12.44% |
| 2006-06-30 | AU$410.58K ≈ $290.51K |
AU$-2.26 Million ≈ $-1.60 Million |
-5.512x | +71.34% |
| 2005-06-30 | AU$186.98K ≈ $132.30K |
AU$-3.60 Million ≈ $-2.54 Million |
-19.232x | -365.33% |
| 2004-06-30 | AU$1.18 Million ≈ $831.58K |
AU$-4.86 Million ≈ $-3.44 Million |
-4.133x | +19.97% |
| 2003-06-30 | AU$967.78K ≈ $684.77K |
AU$-5.00 Million ≈ $-3.54 Million |
-5.164x | -386.06% |
| 2002-06-30 | AU$4.26 Million ≈ $3.01 Million |
AU$-4.52 Million ≈ $-3.20 Million |
-1.063x | -228.39% |
| 2001-06-30 | AU$9.02 Million ≈ $6.39 Million |
AU$-2.92 Million ≈ $-2.07 Million |
-0.324x | -258.68% |
| 2000-06-30 | AU$12.43 Million ≈ $8.80 Million |
AU$-1.12 Million ≈ $-793.44K |
-0.090x | -- |
About Bioxyne Ltd
Bioxyne Limited, together with its subsidiaries, manufactures and distributes therapeutic goods, and health and wellness products in Australia, the United States, the United Kingdom, Czechia, Switzerland, France, Germany, and Japan. It operates through Pharmaceutical Manufacture and Wholesale Supply of Novel Medicines, Cannabis, Psilocybin, and MDMA; Manufacture and Distribution (Wholesale, Onlin… Read more